Wealth manager EQ Investors is to host an impact investing webinar for Financial Planners tomorrow to coincide with Good Money Week which gets under way today.

Good Money Week is an annual campaign to raise awareness of sustainable finance.

EQ says many of the companies in the EQ Positive Impact portfolios provide essential products to healthcare systems worldwide and several are directly involved in fighting the Covid-19 pandemic.

The seminar takes place tomorrow ( Tuesday 27 October at 12 noon) and will last for 1 hour with a 15 minute live audience Q&A.

Among the topics being covered are healthcare, investing in hospitals and coping with Covid-19.

• There will be a company case study on Boston Medical Centre, a not-for-profit hospital.
• Among those taking part will be Kate Walsh, chief executive, Boston Medical Centre; Campe Goodman, fund manager at Wellington Management, Jennifer Soule, analyst, Wellington Management and Louisiana Salge, impact specialist, EQ Investors.
• To register, visit: https://bit.ly/3m1saJj

• As part of Good Money Week HL is running a ‘green takeover’ of its website. The company will also offer advice on responsible investment, how to build a responsible investment portfolio and ethical investing.

Emma Wall, head of investment analysis, Hargreaves Lansdown, said: “Investing with environmental, social and governance concerns in mind is simply good risk management. Businesses are increasingly facing pressure from regulators, society and government which forces them to think longer term, and be mindful of the planet, their employees and the way they make money.

“Respond well, and companies will thrive, fail to engage and firms could face fines, scandal or bankruptcy. It is increasingly clear that companies that are run in a sustainable way are more likely to have sustainable earnings, and therefore make better investments.”

HL said in the 12 months to June, flows into ESG and ethical funds on the HL platform doubled over the year with an significant uptick in flows in April as Coronavirus uncertainty peaked.